Introduction

23
Electroconvulsive therapy (ECT) is effective for patients with 24 depressive disorders, but not all patients benefit. While clinical 25 trials show that the remission rate is often 50% or more after ECT 26 [1,2], a large-scale population-based study in a community setting 27 reported somewhat lower remission rates [3] . 28 Accurate prediction of treatment outcomes in different sub-29 groups of patients with depression are of great importance. 30 Although there are some candidates, a reliable biomarker that 31 predicts responsiveness to ECT has not been established 32 [4, 5] . Therefore, clinicians must rely on clinical history, signs, 33 and symptoms when selecting candidates for ECT. A recent meta-34 analysis showed that shorter episode duration and absence of prior 35 antidepressant medication associate with higher responsiveness to 36 ECT [6] . The impact of several other factors such as age, presence of 37 psychosis, and symptom severity remains unclear due to 38 discrepancies between studies [6].
39
Technical factors may also influence the effectiveness of ECT. 40
The stimulus pulse width is of particular interest because ultra-41 brief (< 0.50 ms) stimulus associates with fewer memory dis-42 turbances than brief (0.50-1.50 ms) pulse stimulus [7, 8] (2014/174) . The patients were informed that their data 151 would be included in the Q-ECT unless they declined to participate. In total, 5976 patients with depression treated in 57 hospitals 155 were included in Q-ECT during the study period. Of these,
